14 result(s) for Prostate
| PI Name | Protocol # | Title |
|---|---|---|
| Tomasz Beer | IRB00002734 | A Randomized Phase II Study of Intermittent chemotherapy or Intermittent Chemotherapy with maintenance GM-CSF in Patients with Previously Untreated Metastatic Hormone Refractory Prostate Cancer |
| Tomasz Beer | IRB00005254 | A Phase II Study of CTLA Blockade by Ipilimumab plus Androgen Suppression Therapy in Patients with an Incomplete Response to AST Alone for Metastatic Prostate Cancer |
| Joshi Alumkal | IRB00005364 | Phase I/II randomized trial of LBH589 (Panobinostat) at two dose levels combined with bicalutamide (Casodex®) in men with castration-resistant prostate cancer |
| Tomasz Beer | IRB00005688 | A Phase II study of MAOA inhibitor plus docetaxel in patients currently receiving and progressing on docetaxel therapy |
| Jackilen Shannon | IRB00006232 | Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation |
| Tomasz Beer | IRB00007590 | A Phase 1 Study of MLN8237, an Aurora A Kinase Inhibitor, in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen |
| Joshi Alumkal | IRB00007640 | A Phase II Study of BKM120 in Men with Metastatic Castration-Resistant Prostate Cancer |
| Tomasz Beer | IRB00007711 | An open-label multicenter study of Sipuleucel-T in metastatic castrate resistant prostate cancer patients previously treated with Sipuleucel-T on Dendreon study P-11 |
| Tomasz Beer | IRB00008569 | A Randomized Phase 3 Study Comparing Cabazitaxel/Prednisone in Combination with Custirsen (OGX-011) to Cabazitaxel/Prednisone for Second-Line Chemotherapy in Men with Metastatic Castrate Resistant Prostate Cancer |
| Tomasz Beer | IRB00008613 | A Multicenter, Single-arm, Open Label Treatment Protocol to Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients with Progressive Castration-Resistant Prostate Cancer Previously Treated with Docetaxel-Based Chemotherapy |
| Joshi Alumkal | IRB00008791 | The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men with Biochemically Relapsed Hormone Sensitive Prostate Cancer |
| Tomasz Beer | IRB00009204 | Radiologically Guided Biopsies of Metastatic Castration Resistant Prostate Cancer to Identify Adaptive Mechanisms of Resistance |
| Joshi Alumkal | IRB00009259 | Identifying Mechanisms of Resistance to Enzalutamide (MDV3100) Treatment in Men with Castration-Resistant Prostate Cancer |
| Tomasz Beer | IRB00009497 | LCCC 1231: Observational Longitudinal Study of Pain in Men with Metastatic Castrate-Resistant Prostate Cancer |
You may qualify for additional trials within our Phase 1 Program